Author

Zhaoqing Wang

Observed names: Z. Wang, Zhao-Qing Wang, Zhao-qing Wang

Observed institutions: Emory University, Harbin Institute of Technology, Purdue University West Lafayette, Hospital of the University of Pennsylvania, Chinese National Human Genome Center, Academy of Military Medical Sciences, Edinburgh Royal Infirmary, Southern University of Science and Technology, British Heart Foundation Centre for Cardiovascular Science, Bristol-Myers Squibb (United States), Shanghai University of Traditional Chinese Medicine, Centre for Inflammation Research, Shenzhen Third People’s Hospital, University of Pennsylvania, Xi'an Jiaotong University, University of Edinburgh, Tsinghua University

ORCID: 0000-0003-1515-4945

Observed ORCID: 0000-0003-1515-4945

OpenAlex ID: A5102004336

A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)

1999 · Bonnie Hsiang, Yingjie Zhu, et al. · Journal of Biological Chemistry · 641

Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction

2020 · Jordana B. Cohen, Sarah J. Schrauben, et al. · JACC Heart Failure · 431

Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay

2010 · Zhaoqing Wang, Charles Frost, et al. · Thrombosis and Haemostasis · 356

Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction

2020 · Julio A. Chirinos, Alena Orlenko, et al. · Journal of the American College of Cardiology · 216

Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils

2016 · Todd G. Kirchgessner, Paul Sleph, et al. · Cell Metabolism · 169

PDF

NF-κB-MediatedHER2Overexpression inRadiation-Adaptive Resistance

2008 · Ning Cao, Shiyong Li, et al. · Radiation Research · 162

PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation

2017 · Simon J. Wilson, Fraz A. Ismat, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 108

PDF

First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor

2021 · Vidya Perera, Zhaoqing Wang, et al. · Clinical and Translational Science · 97

PDF

Protein S-nitrosylation and cancer

2012 · Zhaoqing Wang · Cancer Letters · 96

Haploinsufficiency ofMSX1: a Mechanism for Selective Tooth Agenesis

1998 · Gezhi Hu, Heleni Vastardis, et al. · Molecular and Cellular Biology · 87

PDF

Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure

2020 · Julio A. Chirinos, Lei Zhao, et al. · Circulation · 79

PDF

Endotrophin, a Collagen VI Formation–Derived Peptide, in Heart Failure

2022 · Julio A. Chirinos, Lei Zhao, et al. · NEJM Evidence · 63

PDF

Reversal of apixaban anticoagulation by four‐factor prothrombin complex concentrates in healthy subjects: a randomized three‐period crossover study

2017 · Y. Song, Z. Wang, et al. · Journal of Thrombosis and Haemostasis · 61

Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction

2021 · Ricardo A. García, John A. Lupisella, et al. · JACC Basic to Translational Science · 57

PDF

First‐in‐human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS‐962212, a direct, reversible, small molecule factor XIa inhibitor in non‐Japanese and Japanese healthy subjects

2018 · Vidya Perera, Joseph M. Luettgen, et al. · British Journal of Clinical Pharmacology · 54

PDF

Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure

2020 · Julio A. Chirinos, Jordana B. Cohen, et al. · Hypertension · 52

PDF

Effect of Serum Albumin Levels in Patients With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial)

2019 · Stuart B. Prenner, Anupam Kumar, et al. · The American Journal of Cardiology · 51

Mitogen-activated Protein Kinase Phosphatase-1 Represses c-Jun NH2-terminal Kinase-mediated Apoptosis via NF-κB Regulation

2008 · Zhaoqing Wang, Ning Cao, et al. · Journal of Biological Chemistry · 47

PDF

Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis

2021 · Mahesh K. Vidula, Alena Orlenko, et al. · European Journal of Heart Failure · 38

PDF

A Novel Prothrombin Time Assay for Assessing the Anticoagulant Activity of Oral Factor Xa Inhibitors

2012 · Yu Chen Barrett, Zhaoqing Wang, et al. · Clinical and Applied Thrombosis/Hemostasis · 38

PDF

Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants

2022 · Vidya Perera, Grigor Abelian, et al. · Clinical Pharmacokinetics · 37

PDF

Quantitative Proteomic Analysis of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction

2021 · Thomas C. Hanff, Jordana B. Cohen, et al. · JACC Basic to Translational Science · 34

PDF

Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment

2022 · Vidya Perera, Grigor Abelian, et al. · Clinical Pharmacokinetics · 27

PDF

Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure With Preserved Ejection Fraction

2024 · Joe David Azzo, Marie-Joe Dib, et al. · Circulation Heart Failure · 26

PDF

Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction

2022 · Ali Javaheri, Ahmed Diab, et al. · Circulation Heart Failure · 26

PDF

Works count: 82

Citation count: 3,444

H-index: 26

I10-index: 42